There are 2 types of medications used to treat Alzheimer’s disease. They work differently and are often used together in patients with moderate to severe Alzheimer's disease. This is called combination therapy.
Acetylcholinesterase
inhibitors (AChEIs)
These are thought to work by slowing the breakdown
of a chemical in the brain called acetylcholine.
This chemical is involved in learning and memory.
Glutamate pathway modifiers
(memantine hydrochloride)
These may help regulate the abnormal activity of
glutamate—another chemical in the brain that
is important for learning and memory.
There is no evidence that NAMZARIC, NAMENDA, NAMENDA XR, or an AChEI prevents or slows the underlying disease process in patients with Alzheimer's disease.
NAMZARIC offers combination therapy (NAMENDA XR and donepezil HCl) in a single, once-a-day capsule.
*Aricept® is a trademark used by Eisai Inc. under license from Eisai R&D Management Co., Ltd.
†Razadyne® is a registered trademark of Johnson & Johnson.
‡Exelon® is a registered trademark of Novartis AG Corp.
NAMZARIC is a prescription medicine approved to treat moderate to severe Alzheimer’s disease in patients who are taking donepezil hydrochloride 10 mg.
There is no evidence that NAMZARIC prevents or slows the underlying disease process in patients with Alzheimer's disease.
NAMZARIC should not be taken by anyone who: has an allergy to memantine HCl, donepezil HCl, medicines that contain piperidines, or any of the ingredients in NAMZARIC.
Before taking NAMZARIC, tell the doctor about all of the patient’s medical conditions, including:
Tell the doctor about all the medicines the patient takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
NAMZARIC may cause serious side effects, including:
The most common side effects of memantine HCl include: headache, diarrhea, and dizziness.
The most common side effects of donepezil HCl include: diarrhea, not wanting to eat (anorexia), and bruising.
These are not all the possible side effects of NAMZARIC.
Please also see full Prescribing Information, including Patient Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
USE
NAMZARIC is a prescription medicine approved to treat moderate to severe Alzheimer’s disease in patients who are taking donepezil hydrochloride 10 mg.
There is no evidence that NAMZARIC prevents or slows the underlying disease process in patients with Alzheimer's disease.
USE
NAMZARIC is a prescription medicine approved to treat moderate to severe Alzheimer’s disease in patients who are taking donepezil hydrochloride 10 mg.
There is no evidence that NAMZARIC prevents or slows the underlying disease process in patients with Alzheimer's disease.
NAMZARIC should not be taken by anyone who: has an allergy to memantine HCl, donepezil HCl, medicines that contain piperidines, or any of the ingredients in NAMZARIC.
Before taking NAMZARIC, tell the doctor about all of the patient’s medical conditions, including:
Tell the doctor about all the medicines the patient takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
NAMZARIC may cause serious side effects, including:
The most common side effects of memantine HCl include: headache, diarrhea, and dizziness.
The most common side effects of donepezil HCl include: diarrhea, not wanting to eat (anorexia), and bruising.
These are not all the possible side effects of NAMZARIC.
NAMZARIC is a prescription medicine approved to treat moderate to severe Alzheimer’s disease in patients who are taking donepezil hydrochloride 10 mg.
There is no evidence that NAMZARIC prevents or slows the underlying disease process in patients with Alzheimer's disease.
Please also see full Prescribing Information, including Patient Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
